LFB-R593

monoclonal anti-RhD antibody · Laboratoire français de Fractionnement et de Biotechnologies

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LFB-R593, covering 2011-09-13 to 2011-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Dose-finding Study of LFB-R593, A Monoclonal Anti-RhD Antibody, in Healthy RhD Negative Volunteers [Phase 2]